Literature DB >> 10843422

The potential of active metabolites of antihistamines in the management of allergic disease.

M M Abdelaziz1, O A Khair, J L Devalia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843422     DOI: 10.1034/j.1398-9995.2000.00114.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  3 in total

1.  Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.

Authors:  Doriana Landi; Maria Albanese; Fabio Buttari; Fabrizia Monteleone; Laura Boffa; Silvia Rossi; Caterina Motta; Elisa Puma; Diego Centonze
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

2.  LC-MS/MS metabolomics-facilitated identification of the active compounds responsible for anti-allergic activity of the ethanol extract of Xenostegia tridentata.

Authors:  Rinrada Suntivich; Worawat Songjang; Arunya Jiraviriyakul; Somsak Ruchirawat; Jaruwan Chatwichien
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

3.  Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice.

Authors:  Meng-Li Wu; Feng-Liang Liu; Jing Sun; Xin Li; Jian-Ru Qin; Qi-Hong Yan; Xia Jin; Xin-Wen Chen; Yong-Tang Zheng; Jin-Cun Zhao; Jian-Hua Wang
Journal:  Zool Res       Date:  2022-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.